SCHEMBL15213138

SCHEMBL15213138

CN[C@](C)(C=O)Cc1c[nH]c2cc(Cl)ccc12

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 2/20 0.56
▸ SLC6A4 P31645 1/20 0.46
▸ NR4A2 P43354 1/20 0.42
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ NR3C1 P04150 3/20 0.40
▸ NR3C2 P08235 2/20 0.40
▸ PGR P06401 1/20 0.40
▸ ADRB3 P13945 2/20 0.39
▸ GFER P55789 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ PPARG P37231 1/20 0.38
▸ AHR P35869 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PTGS1 P23219 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22086281 1.00 GPR84 (0.56) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL10068459 0.82 GPR84 (0.55) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL16360806 0.81 MEN1 (0.51) GPR84SLC6A4NR3C1NR3C2PGR
SCHEMBL3184502 0.79 GPR84 (0.67) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL14898398 0.79 GPR84 (0.55) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL19661499 0.79 GPR84 (0.55) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL4492495 0.77 GPR84 (0.52) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL4505527 0.76 GPR84 (0.63) GPR84SLC6A4NR4A2NR3C1NR3C2
SCHEMBL3195765 0.74 GPR84 (0.73) GPR84SLC6A4NR4A2MTNR1AMTNR1B
SCHEMBL27929621 0.74 GPR84 (1.00) GPR84SLC6A4NR4A2ADRB3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017165299-A2 COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2017-09-28 — — WO disclosed
WO-2017044633-A1 PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 AILERON THERAPEUTICS, INC. (US) 2017-03-16 — — WO disclosed
WO-2017004548-A1 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2017-01-05 — — WO disclosed
WO-2016154058-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF AILERON THERAPEUTICS, INC. (US) 2016-09-29 — — WO disclosed
WO-2016049359-A1 PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF AILERON THERAPEUTICS, INC. (US) 2016-03-31 — — WO disclosed
WO-2016049355-A1 PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF AILERON THERAPEUTICS, INC. (US) 2016-03-31 — — WO disclosed
WO-2015157508-A1 PEPTIDOMIMETIC MACROCYCLES WITH PTH ACTIVITY AILERON THERAPEUTICS, INC. (US) 2015-10-15 — — WO disclosed
WO-2013123266-A1 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2013-08-22 — — WO disclosed
WO-2013059525-A1 PEPTIDOMIMETIC MACROCYLES AILERON THERAPEUTICS, INC. (US) 2013-04-25 — — WO disclosed
Send feedback